Lophophine

From WikiMD's Food, Medicine & Wellnesspedia

Lophophine


Lophophine (also known as MMDPEA and 3-Methoxy-4,5-methylenedioxyphenethylamine) is a putative psychedelic and entactogen drug of the phenethylamine class. It is the methoxy analog of MDPEA and is also more distantly related to mescaline.

History[edit | edit source]

Lophophine was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines I Have Known And Loved), the dosage is listed as 150-250 mg, and the duration is listed as 6–8 hours. Shulgin reports that lophophine has a unique property among psychedelics: it does not induce the visual effects typically associated with other psychedelic drugs.

Pharmacology[edit | edit source]

The pharmacology of lophophine is not well known, but it is likely to act by increasing levels of serotonin, dopamine, and norepinephrine in the brain. It may also act on the serotonin receptors, specifically the 5-HT2A receptor, which is known to be responsible for the effects of many psychedelic drugs.

Legal Status[edit | edit source]

Lophophine is not controlled in the United States and is therefore legal to buy, possess, and sell. However, it could potentially be considered an analog of a Schedule I drug under the Federal Analogue Act if it is intended for human consumption.

See Also[edit | edit source]

Template:Psychoactive drug

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD